Severe Allergic Reactions

Also known as: Severe allergic reaction

Drug	Drug Name	Drug Description
DB00297	Bupivacaine	A local anesthetic used in a wide variety of superficial and invasive procedures.
DB14545	Hydrocortisone succinate	A corticosteroid used to treat severe allergic reactions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematological disorders, neoplastic diseases, nervous system conditions, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders.
DB14644	Methylprednisolone hemisuccinate	A water soluble corticosteroid used to treat severe allergic reactions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematological disorders, neoplastic diseases, nervous system conditions, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders.

Drug	Drug Name	Target	Type
DB00297	Bupivacaine	Sodium channel protein type 10 subunit alpha	target
DB00297	Bupivacaine	Prostaglandin E2 receptor EP1 subtype	target
DB00297	Bupivacaine	Cytochrome P450 3A4	enzyme
DB00297	Bupivacaine	Cytochrome P450 2C19	enzyme
DB00297	Bupivacaine	Cytochrome P450 2D6	enzyme
DB14545	Hydrocortisone succinate	Cytochrome P450 3A4	enzyme
DB14545	Hydrocortisone succinate	Cytochrome P450 2C8	enzyme
DB14545	Hydrocortisone succinate	Cytochrome P450 11B1, mitochondrial	enzyme
DB14545	Hydrocortisone succinate	Cytochrome P450 11B2, mitochondrial	enzyme
DB14644	Methylprednisolone hemisuccinate	Cytochrome P450 3A4	enzyme
DB14644	Methylprednisolone hemisuccinate	Cytochrome P450 3A5	enzyme

Drug	Drug Name	Phase	Status	Count